PPARGC1A and nonpapillary renal cell carcinoma: Another research group described a novel role for PGC-1α, whereby the PGC-1α/miR-29 axis attenuates the epithelial-to-mesenchymal transition (EMT) program to prevent ccRCC tumor progression [71].